Lokeren, Belgium

Kevin Braeckmans

This inventor holds 3 USPTO granted patents and 1 published patent application and 3 EPO patents. Top assignees: University of Ghent, Centrale Lille Institute, Centre National De La Recherche Scientifique. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kevin Braeckmans. Retrieved from https://idiyas.com/inventor/kevin-braeckmans-hwqqdwy7

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.8

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Kevin Braeckmans: Innovator in Cell Permeability and Vitreous Treatment

Introduction

Kevin Braeckmans is a notable inventor based in Lokeren, Belgium. He has made significant contributions to the field of biomedical engineering, particularly in methods that enhance cell permeability and treat vitreous disorders. With a total of three patents to his name, Braeckmans continues to push the boundaries of scientific innovation.

Latest Patents

One of Braeckmans' latest patents is a method to increase the permeability of the plasma membrane of cells. This invention involves introducing at least one cell on or near a structure comprising particles that can absorb electromagnetic radiation. The particles are embedded in the material of the structure at a concentration ranging from 0.001 vol % to 20 vol %. Notably, at least 60% of these particles are embedded in such a way that the shortest distance between the particles and the free area surface of the structure ranges from 1 nm to 500 nm. This method is designed for use in photothermal processes to permeabilize cells effectively.

Another significant patent by Braeckmans is a composition for the treatment of vitreous disease or disorder. This composition includes particles that serve as a light-sensitizing agent. Each particle is specifically designed to provide mobility within the vitreous and to bind to collagen aggregates, such as floaters. These innovations reflect Braeckmans' commitment to advancing medical treatments.

Career Highlights

Throughout his career, Kevin Braeckmans has worked with esteemed institutions, including Ghent University and the Centre National de la Recherche Scientifique (CNRS). His work has been instrumental in developing new methodologies and compositions that address critical health issues.

Collaborations

Braeckmans has collaborated with notable colleagues, including Ranhua Xiong and Stefaan De Smedt. These partnerships have fostered a collaborative environment that enhances research and innovation in their respective fields.

Conclusion

Kevin Braeckmans stands out as an influential inventor whose work in cell permeability and vitreous treatment has the potential to impact medical science significantly. His innovative patents and collaborations highlight his dedication to advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…